Skip to content

A clinical efficacy study of Sodium phenylbutyrate in the treatment of diminished ovarian reserve

A clinical efficacy study of Sodium phenylbutyrate in the treatment of diminished ovarian reserve

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101552
Enrollment
Unknown
Registered
2025-04-27
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve

Interventions

Diminished ovarian reserve:Treatment with sodium phenylbutyrate

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. 20 years old= 10 b. Number of follicles in the ovarian sinus (AFC) < 5 c. AMH < 1.1 ng/ml

Exclusion criteria

Exclusion criteria: 1. Those with a history of ovarian or pelvic surgery, chemotherapy and radiotherapy in the past; 2. Patients with viral infections such as hepatitis, tumors, autoimmune diseases, endocrine diseases, metabolic diseases and acute inflammation; 3. Have a clear family history or hereditary factors of hereditary premature ovarian failure 4. Combined with hyperprolactinemia and endometriosis; 5. Pregnancy or lactation; 6. Patients who are allergic to active ingredients and excipients are prohibited; 7. Suffering from other serious heart, liver, kidney and other important organ diseases or tumors; 8. Those who have a history of taking hormone drugs in the past 2 months or those who have amenorrhea caused by drugs; 9. The investigator believes that the subject has any other factors that may affect the efficacy or safety evaluation of this study, and is not suitable to participate in this study

Design outcomes

Primary

MeasureTime frame
Bilateral antral follicle count;Anti Mullerian hormone;

Secondary

MeasureTime frame
Follicle stimulating hormone;Insulin resistance index for a homeostatic model;

Countries

China

Contacts

Public ContactLiangshan Mu

Zhongshan Hospital, Fudan University

mu.liangshan@zs-hospital.sh.cn+86 188 1782 1283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026